2 patents
Utility
Epigeneiic silencing of NMT2
17 Oct 23
The finding that multiple cancers lack one of two NMTs, while stromal and normal tissues do not, enables the treatment of NMT2-deficient cancer cells with an NMT inhibitor.
Luc G. Berthiaume, Erwan Beauchamp
Filed: 18 Jul 16
Utility
Synthetic lethality and the treatment of cancer
5 Oct 21
Described herein are compounds, compositions and methods for treatment of cancer.
Luc G. Berthiaume, Erwan Beauchamp, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap
Filed: 2 Jul 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first